Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ruxolitinib”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07802405
What this trial is testing

Evaluating Safety ,Tolerability, Pharmacokinetic,Efficacy of WJ01024 or WJ01024 Combined With Ruxolitinib in Patients With Myelofibrosis

Who this might be right for
MF With Splenomegaly
Henan Cancer Hospital 20
Early research (Phase 1)Study completedNCT05121142
What this trial is testing

Study of Ruxolitinib for Acute and Chronic Graft Versus Host Disease

Who this might be right for
Acute-graft-versus-host DiseaseChronic Graft-versus-host-diseaseSolid Organ Transplant
Children's Hospital Medical Center, Cincinnati 13
Testing effectiveness (Phase 2)Study completedNCT01594216
What this trial is testing

Ruxolitinib in Estrogen Receptor Positive Breast Cancer

Who this might be right for
Estrogen-receptor Positive Invasive Metastatic Breast Cancer
Abramson Cancer Center at Penn Medicine 25
Not applicableNo Longer AvailableNCT04337359
What this trial is testing

Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 Illness

Who this might be right for
Severe/Very Severe COVID-19 Illness
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)UnknownNCT05413356
What this trial is testing

Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome

Who this might be right for
Bronchiolitis Obliterans SyndromeHematologic Malignancy
First Affiliated Hospital of Zhejiang University 50
Testing effectiveness (Phase 2)Study completedNCT01950780
What this trial is testing

Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata

Who this might be right for
Alopecia Areata
Columbia University 12
Testing effectiveness (Phase 2)Study completedNCT01732445
What this trial is testing

Ruxolitinib Phosphate and Danazol in Treating Anemia in Patients With Myelofibrosis

Who this might be right for
AnemiaPrimary MyelofibrosisSecondary Myelofibrosis
Mayo Clinic 14
Large-scale testing (Phase 3)Study completedNCT03952039
What this trial is testing

An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermediate or High-risk Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib

Who this might be right for
Primary MyelofibrosisPost-Polycythemia VeraMyelofibrosis
Celgene 202
Testing effectiveness (Phase 2)Study completedNCT01693601
What this trial is testing

Panobinostat and Ruxolitinib In MyElofibrosis (PRIME Trial)

Who this might be right for
Myelofibrosis
John Mascarenhas 15
Testing effectiveness (Phase 2)Ended earlyNCT04807777
What this trial is testing

Study of Ruxolitinib in Solid Organ Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma

Who this might be right for
Advanced Cutaneous Squamous Cell Carcinoma
Columbia University 3
Testing effectiveness (Phase 2)Study completedNCT02092324
What this trial is testing

Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia

Who this might be right for
Atypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeChronic Neutrophilic Leukemia
OHSU Knight Cancer Institute 51
Large-scale testing (Phase 3)Ended earlyNCT04551066
What this trial is testing

To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)

Who this might be right for
MyelofibrosisPrimary MyelofibrosisPost Essential Thrombocythemia Myelofibrosis+1 more
Incyte Corporation 252
Testing effectiveness (Phase 2)Study completedNCT03099304
What this trial is testing

INCB018424 Phosphate Cream in Subjects With Vitiligo

Who this might be right for
Vitiligo
Incyte Corporation 157
Early research (Phase 1)Study completedNCT03514069
What this trial is testing

Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma

Who this might be right for
GliomaGlioblastoma
Case Comprehensive Cancer Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT05037760
What this trial is testing

Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis

Who this might be right for
Myelofibrosis
Takeda 135
Early research (Phase 1)Ended earlyNCT03935555
What this trial is testing

Assess the Safety, Tolerability Oral PU-H71 in Subjects Taking Ruxolitinib

Who this might be right for
Primary Myelofibrosis (PMF)Post-Polycythemia Vera Myelofibrosis (Post-PV MF)Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF)
Samus Therapeutics, Inc. 11
Testing effectiveness (Phase 2)Study completedNCT00778700
What this trial is testing

A Dose Ranging Study of the Effect of Ruxolitinib Phosphate Cream When Applied to Participants With Plaque Psoriasis

Who this might be right for
Psoriasis
Incyte Corporation 199
Testing effectiveness (Phase 2)Study completedNCT02806375
What this trial is testing

PTCy and Ruxolitinib GVHD Prophylaxis in Myelofibrosis

Who this might be right for
Primary MyelofibrosisMyeloproliferative Disorders
St. Petersburg State Pavlov Medical University 20
Testing effectiveness (Phase 2)Looking for participantsNCT04644211
What this trial is testing

Ruxolitinib in Thrombocythemia and Polycythemia Vera

Who this might be right for
Essential ThrombocythemiaPolycythemia Vera
Massachusetts General Hospital 60
Early research (Phase 1)Looking for participantsNCT05423691
What this trial is testing

Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

Who this might be right for
Myelofibrosis
Cellenkos, Inc. 24
Next Page